Chronic Therapy with Nipradilol, a .BETA.-Adrenergic Blocker, Attenuated Left Ventricular Remodeling Following Myocardial Infarction in Rats.
-
- Sonoki Hiroyuki
- Tokyo Research Laboratories, Kowa Co., Ltd.
-
- Nakamura Masaki
- Tokyo Research Laboratories, Kowa Co., Ltd.
-
- Takeshita Akira
- Research Institute of Angiocardiology and Cardiovascular Clinic, Faculty of Medicine, Kyushu University
Bibliographic Information
- Other Title
-
- Chronic Therapy with Nipradilol,a β-Adrenergic Blocker,Attenuated Left Ventricular Remodeling Following Myocardial Infarction in Rats
- Chronic Therapy with Nipradilol a ベータ A
Search this article
Abstract
We determined whether chronic treatment with nipradilol, a β-blocker with vasodilating action, reduces left ventricular cavity dilation (LV remodeling) following myocardial infarction and improves cardiac performance. Myocardial infarction was produced by coronary artery ligation in 16-week-old female rats and then the rats were treated for 3-4 months with nipradilol (10 mg/kg/day) or vehicle (0.5% carboxymethylcellulose). The effect of nipradilol on LV remodeling was evaluated by assessing the left ventricular end-diastolic volume index (LVEDVI)and passive pressure-volume relation curve. Since LVEDVI depends on the infarct size, LVEDVI was compared between the vehicle and nipradilol-treated rats with similar infarct size (10-40%). At 3-4 months after myocardial infarct production, the left ventricular end-diastolic volume index in the vehicle-treated rats with myocardial infarction was significantly increased, compared with that in the sham-operated rats without infarction. The nipradilol-treated rats had a significantly smaller left ventricular volume index than the vehicle-treated rats (2.04±0.16 ml/kg in the vehicle-treated group vs 1.36±0.10 ml/kg in the nipradilol-treated group, P<0.01). The maximum cardiac index achieved by volume loading as an index of cardiac performance was significantly greater in the nipradilol group than the vehicle group (254.5 ± 12.6 ml/min kg in the vehicle group vs 347.9 ± 20.2 ml/min kg in the nipradilol group, P <0.01). These results suggest that chronic treatment of nipradilol attenuated left ventricular cavity dilation after myocardial infarction and improved cardiac performance.
Journal
-
- The Japanese Journal of Pharmacology
-
The Japanese Journal of Pharmacology 74 (2), 171-178, 1997
The Japanese Pharmacological Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679263001472
-
- NII Article ID
- 10008678904
-
- NII Book ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK2sXktVOgsbk%3D
-
- ISSN
- 13473506
- 00215198
- http://id.crossref.org/issn/00215198
-
- NDL BIB ID
- 4260346
-
- PubMed
- 9243325
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed